|
LOC652276 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.15980000000716E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.235190E-03 |
| Normal-vs-Stage2 |
4.541600E-02 |
| Normal-vs-Stage3 |
3.457600E-03 |
| Normal-vs-Stage4 |
2.616200E-01 |
| Stage1-vs-Stage2 |
7.638200E-01 |
| Stage1-vs-Stage3 |
2.568800E-01 |
| Stage1-vs-Stage4 |
7.478400E-01 |
| Stage2-vs-Stage3 |
5.901200E-01 |
| Stage2-vs-Stage4 |
6.522800E-01 |
| Stage3-vs-Stage4 |
3.630400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.75520000000363E-05 |
| Normal-vs-AfricanAmerican |
1.045560E-02 |
| Normal-vs-Asian |
4.403000E-01 |
| Caucasian-vs-AfricanAmerican |
4.114400E-01 |
| Caucasian-vs-Asian |
6.984500E-02 |
| AfricanAmerican-vs-Asian |
1.173240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.600000E-04 |
| Normal-vs-Female |
2.610000E-04 |
| Male-vs-Female |
3.614200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.194000E-02 |
| Normal-vs-Extreme_Weight |
8.443500E-03 |
| Normal-vs-Obese |
1.796760E-04 |
| Normal-vs-Extreme_Obese |
1.578560E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.122200E-01 |
| Normal_Weight-vs-Obese |
8.270400E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.882800E-01 |
| Extreme_Weight-vs-Obese |
7.998100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.423600E-01 |
| Obese-vs-Extreme_Obese |
3.255200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.737960E-03 |
| Normal-vs-Age(41-60Yrs) |
1.90934999999559E-05 |
| Normal-vs-Age(61-80Yrs) |
6.897800E-03 |
| Normal-vs-Age(81-100Yrs) |
1.118410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.559800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.854610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.128000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.465900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.709000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.940400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.553700E-04 |
| Normal-VS-Type2 PRCC |
2.438400E-02 |
| Normal-VS-KIRP CIMP |
1.137590E-02 |
| Normal-VS-Unclassified PRCC |
2.826700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.242600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.035160E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.604300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.443960E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.755900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.787200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.383600E-02 |
| Normal-vs-N1 |
1.702320E-03 |
| Normal-vs-N2 |
2.328400E-01 |
| N0-vs-N1 |
2.232800E-01 |
| N0-vs-N2 |
9.391400E-01 |
| N1-vs-N2 |
6.079600E-01 |
|
|
